Investors NYSE MKT: LCTX Copyright West LLC. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases February 18, 2020 Lineage Cell Therapeutics to Present New Data From OpRegen® and Vision Restoration Programs at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2020) February 10, 2020 Lineage Cell Therapeutics to Present at NobleCon16 - Noble Capital Markets' Sixteenth Annual Investor Conference February 06, 2020 Lineage Provides Positive Update on Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics at NobleCon16 - Noble Capital Markets’ Sixteenth Annual Investor Conference Feb 18, 2020 at 2:30 PM EST Lineage Cell Therapeutics at Solebury Trout’s KOL Event Nov 15, 2019 at 11:00 AM EST Q3 2019 Lineage Cell Therapeutics Earnings Conference Call Nov 12, 2019 at 1:30 PM PST VIEW EVENTS & PRESENTATIONS
February 18, 2020 Lineage Cell Therapeutics to Present New Data From OpRegen® and Vision Restoration Programs at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2020)
February 10, 2020 Lineage Cell Therapeutics to Present at NobleCon16 - Noble Capital Markets' Sixteenth Annual Investor Conference
February 06, 2020 Lineage Provides Positive Update on Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration
Lineage Cell Therapeutics at NobleCon16 - Noble Capital Markets’ Sixteenth Annual Investor Conference Feb 18, 2020 at 2:30 PM EST
